<DOC>
	<DOCNO>NCT03077841</DOCNO>
	<brief_summary>The goal clinical research study learn side effect may occur radiation give breast cancer patient 2 2½ week part breast disease first start . Researchers also want learn treatment help control disease prevent cancer come back breast .</brief_summary>
	<brief_title>Optimizing Preventative Adjuvant Linac-Based Radiation : OPAL Trial - Study Hypofractionated Partial Breast Irradiation Women With Early Stage Breast Cancer</brief_title>
	<detailed_description>If agree take part study , one ( 1 ) time begin radiation treatment : - You complete 1 questionnaire breast currently look feel . It take 10 minute complete questionnaire . - The study team take picture breast compare way look begin receive radiation . Your face cover ( much possible ) include picture . Length Study : You receive radiation 2 2½ week . You longer able receive radiation intolerable side effect occur , unable follow study direction . Your participation 5-year follow-up visit . Study Treatment Administration : If agree take part study , receive 2 week radiation ( 10 treatment ) part breast disease first start . If doctor think need , 3 additional radiation treatment `` boost . '' The boost deliver focus closely part breast disease first start . Follow-Up Visits : 3 week finish receive radiation , physical exam . You return additional follow-up visit 6 month 1 , 2 , 3 , 4 , 5 year finish receive radiation . At visit : - You complete study questionnaire - The study team take picture breast . - You physical exam . This investigational study . Radiation therapy deliver use FDA approve commercially available method . The short radiation treatment period consider investigational . The study doctor explain radiation design work . Up 100 participant enrol study . All take part MD Anderson .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Neoplasms</mesh_term>
	<criteria>1 . Age 50 old . 2 . Female sex . 3 . Diagnosis pathologicallyconfirmed invasive breast cancer ductal carcinoma situ . 4 . Pathologic T stage Tis , T1 , T2 total size tumor &lt; /= 3 cm ( size criterion apply pure DCIS invasive tumor ) . 5 . For patient invasive breast cancer , pathologic N stage N0 , N0 ( ) , N0 ( i+ ) . Pathologic stag axilla require patient pure DCIS . 6 . Treatment breast conserve surgery . 7 . Unifocal primary tumor base image clinical assessment . Microscopic multifocality allow . 8 . Final surgical margin negative defined tumor ink . Lobular carcinoma situ involve final surgical margin disregard . 9 . For invasive cancer , tumor must estrogen receptor positive ( defined 10 % great expression estrogen receptor ) 10 . If patient history prior nonbreast cancer , treatment cancer must complete least one month prior study registration patient must evidence disease prior nonbreast cancer . 11 . Patients must enrol trial within 12 week later two date : final breast conserve surgical procedure administration last cycle cytotoxic chemotherapy . 12 . Final criterion eligibility establish simulation : The tumor bed readily visualize simulation CT localize one quadrant region breast amenable partial breast irradiation . 1 . Tumor invasion skin include dermis , chest wall , pectoralis musculature . 2 . Any evidence nodal positivity beyond pathologic stage pN0 ( i+ ) . 3 . Systemic chemotherapy prior final breast conserving surgery . 4 . Patient pregnant nursing . 5 . History therapeutic irradiation breast , low neck , mediastinum area could potentially overlap affected breast . 6 . History prior invasive situ cancer either breast . 7 . Current diagnosis bilateral breast cancer . 8 . History lupus scleroderma .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Malignant neoplasm breast</keyword>
	<keyword>Breast cancer</keyword>
	<keyword>Radiation therapy</keyword>
	<keyword>XRT</keyword>
	<keyword>External beam radiation therapy</keyword>
	<keyword>Shorter course</keyword>
	<keyword>Questionnaires</keyword>
	<keyword>Surveys</keyword>
</DOC>